Synchron launches incentive for vaccinated advisers

COVID-19 vaccine speed unlikely to become norm

COVID-19 vaccine will not invalidate life insurance

The possible $4bn cost to vaccine roll-out delay

Expect ‘prolonged dip’ in SEA EMs

Median balanced super fund up 0.7% in February

Investors 'oblivious' of vaccine failure risks warns Magellan's Douglass

Australia to recover sooner than expected

Global credit to see a cyclical recovery in 2021

Don’t forget to consider COVID vaccine losers: T. Rowe Price

The stocks rising most on the COVID-19 vaccine success

Investors risk being caught out by market rotation

Platinum’s Ogden backs COVID-19 vaccine creators

Race ramps up between Pfizer and Moderna

From the folks who brought you Viagra – a vaccine